Caremark

The Big Three PBMs’ 2023 Formulary Exclusions: Observations on Insulin, Humira, and Biosimilars
The Big Three PBMs’ 2023 Formulary Exclusions: Observations on Insulin, Humira, and Biosimilars
Drug Channels
PBMs
Caremark
CVS Health
Express Scripts
Cigna
OptumRx
United Health
formularies
insulin
biosimilars
Humira
Flag link:
Five Takeaways from the Big Three PBMs’ 2022 Formulary Exclusions
Five Takeaways from the Big Three PBMs’ 2022 Formulary Exclusions
Drug Channels
PBMs
formularies
CVS Health
Caremark
Express Scripts
OptumRx
insulin
Flag link:
Sanofi, Lilly, Novo and a trio of PBMs face racketeering claims over pricey insulin drugs
Sanofi, Lilly, Novo and a trio of PBMs face racketeering claims over pricey insulin drugs
Fierce Pharma
Sanofi
Eli Lilly
Novo Nordisk
PBMs
Caremark
Express Scripts
RICO
racketeering
insulin
drug pricing
diabetes
Flag link:
Ending Pharmacy Dispute, Walmart Renews Contract With CVS Heath's PBM
Ending Pharmacy Dispute, Walmart Renews Contract With CVS Heath's PBM
Forbes
CVS Health
Walmart
Caremark
PBMs
Flag link:
Vivus Scores Insurance Win
Vivus Scores Insurance Win
Seeking Alpha
Vivus
Orexigen
obesity
insurance
Caremark
Arena Pharmaceuticals
Qsymia
Flag link:
2 Healthcare Stocks To Consider In The Wake Of 30% Dividend Hikes
2 Healthcare Stocks To Consider In The Wake Of 30% Dividend Hikes
Seeking Alpha
Amgen
Caremark
Flag link:
Allergan estimates lowered on CVS/Caremark exclusion, says Leerink
Allergan estimates lowered on CVS/Caremark exclusion, says Leerink
The Fly on the Wall
Allergan
CVS
Caremark
Flag link: